We are live on ! Find out more
NUVA

NuVasive, Inc.

Delisted

NUVA was delisted on the 31st of August, 2023.

259 hedge funds and large institutions have $3.69B invested in NuVasive, Inc. in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 87 increasing their positions, 88 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 33

2% more capital invested

Capital invested by funds: $3.62B → $3.69B (+$78.8M)

0% less funds holding

Funds holding: 260259 (-1)

1% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 88

22% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $15.8M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
259
Holders Change
-1
Holders Change %
-0.38%
% of All Funds
4.49%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
34
Increased
87
Reduced
88
Closed
33
Calls
$12.4M
Puts
$15.8M
Net Calls
-$3.44M
Net Calls Change
-$9.62M

NUVA Hedge Fund Activity: Q2 2021 in Review

259 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2021, worth a combined $3.69B — up 2.2% from $3.62B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NUVA positions and 33 closed out — a net gain of 1 holder — while 87 added to existing stakes and 88 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $82.6M. The largest seller was Victory Capital Management, cutting an estimated $45.8M.

  • 259 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2021, down from 260 in Q1 2021.
  • Funds reported $3.69B of NuVasive, Inc. stock for Q2 2021, up 2.2% quarter-over-quarter.
  • 34 funds opened new NuVasive, Inc. positions in Q2 2021 and 33 closed out, a net change of +1 holder.
  • The largest NuVasive, Inc. buyer in Q2 2021 was JP Morgan Chase, an estimated $82.6M added.
  • The largest NuVasive, Inc. seller in Q2 2021 was Victory Capital Management, an estimated $45.8M sold.

Based on aggregated 13F filings for Q2 2021.